Washington DC [US], July 18 (ANI): According to Rutgers researchers, the majority of people with multiple sclerosis (MS) choose oral medications to treat chronic and progressive neurological illnesses. This is likely due to a variety of variables, including convenience, consumer promotion, and approval by health insurers. Also Read | Penis…Read More
Health News Research Reveals Oral Medication is Leading Choice for Multiple Sclerosis Treatment LatestLY
